|
|
Volumn 7, Issue 2, 2005, Pages 111-116
|
|
Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZOTHIADIAZINE DERIVATIVE;
CHOLESTEROL;
DIURETIC AGENT;
GLUCOSE;
THIAZIDE DIURETIC AGENT;
BLOOD;
BLOOD PRESSURE;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
HUMAN;
HYPERTENSION;
HYPOKALEMIA;
INSULIN RESISTANCE;
METABOLISM;
REVIEW;
TREATMENT OUTCOME;
BENZOTHIADIAZINES;
BLOOD PRESSURE;
CHOLESTEROL;
DIURETICS;
GLUCOSE;
HUMANS;
HYPERTENSION;
HYPOKALEMIA;
INSULIN RESISTANCE;
SODIUM CHLORIDE SYMPORTER INHIBITORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 20644445672
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2005.03943.x Document Type: Review |
|
Times cited : (8)
|
|
References (45)
|
